IS2253B - Notkun á eletriptani til fyrirbyggingar á endurteknu mígreni - Google Patents
Notkun á eletriptani til fyrirbyggingar á endurteknu mígreniInfo
- Publication number
- IS2253B IS2253B IS5771A IS5771A IS2253B IS 2253 B IS2253 B IS 2253B IS 5771 A IS5771 A IS 5771A IS 5771 A IS5771 A IS 5771A IS 2253 B IS2253 B IS 2253B
- Authority
- IS
- Iceland
- Prior art keywords
- eletriptan
- repeated
- migraine prevention
- migraine
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9816556.6A GB9816556D0 (en) | 1998-07-30 | 1998-07-30 | Therapy |
| PCT/IB1999/001105 WO2000006161A1 (en) | 1998-07-30 | 1999-06-14 | Prevention of migraine recurrence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS5771A IS5771A (is) | 2000-12-15 |
| IS2253B true IS2253B (is) | 2007-06-15 |
Family
ID=10836395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5771A IS2253B (is) | 1998-07-30 | 2000-12-15 | Notkun á eletriptani til fyrirbyggingar á endurteknu mígreni |
Country Status (36)
| Country | Link |
|---|---|
| EP (3) | EP1466601A3 (is) |
| JP (1) | JP3824863B2 (is) |
| KR (2) | KR20030078876A (is) |
| CN (2) | CN1522697A (is) |
| AP (1) | AP1402A (is) |
| AT (1) | ATE261304T1 (is) |
| AU (1) | AU3952199A (is) |
| BG (1) | BG65309B1 (is) |
| BR (1) | BR9912588A (is) |
| CA (1) | CA2338901C (is) |
| CZ (1) | CZ2001357A3 (is) |
| DE (1) | DE69915486T2 (is) |
| DK (1) | DK1100499T3 (is) |
| EA (2) | EA200201149A1 (is) |
| EE (1) | EE04703B1 (is) |
| ES (1) | ES2214027T3 (is) |
| GB (1) | GB9816556D0 (is) |
| GE (2) | GEP20063719B (is) |
| HK (1) | HK1038198A1 (is) |
| HR (1) | HRP20010079A2 (is) |
| HU (1) | HUP0103424A3 (is) |
| ID (1) | ID26996A (is) |
| IL (1) | IL140169A0 (is) |
| IS (1) | IS2253B (is) |
| NO (1) | NO20010489L (is) |
| NZ (2) | NZ508736A (is) |
| OA (1) | OA11576A (is) |
| PL (1) | PL194611B1 (is) |
| PT (1) | PT1100499E (is) |
| SG (1) | SG125910A1 (is) |
| SK (1) | SK1182001A3 (is) |
| TR (1) | TR200100314T2 (is) |
| TW (2) | TW537893B (is) |
| UA (1) | UA76399C2 (is) |
| WO (1) | WO2000006161A1 (is) |
| YU (2) | YU6401A (is) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| GB9915231D0 (en) * | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| CN1176649C (zh) * | 2002-10-16 | 2004-11-24 | 上海医药工业研究院 | 舒马普坦干粉吸入剂及其制备方法 |
| MXPA05006954A (es) | 2002-12-26 | 2005-09-22 | Pozen Inc | Formas de dosificacion de capas multiples que contienen nsaids y triptanos. |
| CA2521902A1 (en) | 2003-04-11 | 2004-10-21 | Pfizer Inc. | Pharmaceutical combination comprising eletriptan and sodium bicarbonate |
| GB2407498B (en) * | 2003-10-30 | 2008-06-11 | Cipla Ltd | Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient |
| FR2926721B1 (fr) * | 2008-01-30 | 2011-07-22 | Philippe Perovitch | Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans |
| EP2306998A4 (en) | 2008-06-20 | 2011-06-15 | Alphapharm Pty Ltd | PHARMACEUTICAL FORMULATION |
| WO2011048496A1 (en) * | 2009-10-23 | 2011-04-28 | Fortuderm, Ltd. | Triptans for the treatment of psoriasis |
| NO2838517T3 (is) | 2012-04-18 | 2018-03-17 | ||
| CN103385876B (zh) * | 2012-05-08 | 2016-01-13 | 四川滇虹医药开发有限公司 | 一种夫罗曲坦的药物组合物及其制备方法 |
| CN104523709A (zh) * | 2014-12-22 | 2015-04-22 | 青岛正大海尔制药有限公司 | 一种含有琥珀酸夫罗曲坦的复方缓释制剂 |
| WO2018011181A1 (en) | 2016-07-11 | 2018-01-18 | Contera Pharma Aps | Pulsatile drug delivery system for treating morning akinesia |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992006973A1 (en) * | 1990-10-15 | 1992-04-30 | Pfizer Inc. | Indole derivatives |
| EP0546593B1 (en) * | 1991-10-30 | 1997-09-03 | Glaxo Group Limited | Multi-layered compositions containing histamine or serotonin antagonists |
| US5464633A (en) * | 1994-05-24 | 1995-11-07 | Jagotec Ag | Pharmaceutical tablets releasing the active substance after a definite period of time |
| GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| US5744482A (en) * | 1994-10-05 | 1998-04-28 | Eli Lilly And Company | Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine |
| US5698571A (en) * | 1994-10-05 | 1997-12-16 | Eli Lilly And Company | 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
| JP2000505090A (ja) * | 1996-07-11 | 2000-04-25 | ファーマーク、ニーダーランド、ベスローテン、フェンノートシャップ | インドール選択的セロトニンアゴニストを含む包接錯体 |
| JP3350061B2 (ja) * | 1997-07-03 | 2002-11-25 | ファイザー・インク | エレトリプタンヘミスルフェートおよびカフェインを含有する医薬組成物 |
| US6514530B2 (en) * | 1997-09-09 | 2003-02-04 | Alza Corporation | Dosage form comprising means for changing drug delivery shape |
-
1998
- 1998-07-30 GB GBGB9816556.6A patent/GB9816556D0/en not_active Ceased
-
1999
- 1999-06-14 TR TR2001/00314T patent/TR200100314T2/xx unknown
- 1999-06-14 IL IL14016999A patent/IL140169A0/xx unknown
- 1999-06-14 PL PL99345803A patent/PL194611B1/pl not_active IP Right Cessation
- 1999-06-14 EP EP04004643A patent/EP1466601A3/en not_active Withdrawn
- 1999-06-14 CN CNA2003101025101A patent/CN1522697A/zh active Pending
- 1999-06-14 AU AU39521/99A patent/AU3952199A/en not_active Abandoned
- 1999-06-14 EA EA200201149A patent/EA200201149A1/ru unknown
- 1999-06-14 SK SK118-2001A patent/SK1182001A3/sk unknown
- 1999-06-14 EA EA200100089A patent/EA004036B1/ru not_active IP Right Cessation
- 1999-06-14 CZ CZ2001357A patent/CZ2001357A3/cs unknown
- 1999-06-14 EP EP04004644A patent/EP1435237A1/en not_active Withdrawn
- 1999-06-14 ID IDW20010229A patent/ID26996A/id unknown
- 1999-06-14 GE GEAP19996881A patent/GEP20063719B/en unknown
- 1999-06-14 OA OA1200000354A patent/OA11576A/en unknown
- 1999-06-14 NZ NZ508736A patent/NZ508736A/en unknown
- 1999-06-14 GE GEAP19995732A patent/GEP20043157B/en unknown
- 1999-06-14 PT PT99922459T patent/PT1100499E/pt unknown
- 1999-06-14 UA UA2001010653A patent/UA76399C2/uk unknown
- 1999-06-14 EE EEP200100061A patent/EE04703B1/xx not_active IP Right Cessation
- 1999-06-14 YU YU6401A patent/YU6401A/sh unknown
- 1999-06-14 WO PCT/IB1999/001105 patent/WO2000006161A1/en active IP Right Grant
- 1999-06-14 KR KR10-2003-7008744A patent/KR20030078876A/ko not_active Application Discontinuation
- 1999-06-14 BR BR9912588-9A patent/BR9912588A/pt not_active Application Discontinuation
- 1999-06-14 SG SG200300769A patent/SG125910A1/en unknown
- 1999-06-14 YU YU20303A patent/YU20303A/sh unknown
- 1999-06-14 DK DK99922459T patent/DK1100499T3/da active
- 1999-06-14 EP EP99922459A patent/EP1100499B1/en not_active Expired - Lifetime
- 1999-06-14 DE DE69915486T patent/DE69915486T2/de not_active Expired - Fee Related
- 1999-06-14 AP APAP/P/2001/002056A patent/AP1402A/en active
- 1999-06-14 JP JP2000562016A patent/JP3824863B2/ja not_active Expired - Fee Related
- 1999-06-14 CN CNB998087378A patent/CN1155379C/zh not_active Expired - Fee Related
- 1999-06-14 CA CA002338901A patent/CA2338901C/en not_active Expired - Fee Related
- 1999-06-14 ES ES99922459T patent/ES2214027T3/es not_active Expired - Lifetime
- 1999-06-14 HU HU0103424A patent/HUP0103424A3/hu unknown
- 1999-06-14 AT AT99922459T patent/ATE261304T1/de not_active IP Right Cessation
- 1999-06-14 KR KR10-2001-7001231A patent/KR100441732B1/ko not_active IP Right Cessation
- 1999-06-17 TW TW088110233A patent/TW537893B/zh not_active IP Right Cessation
- 1999-06-17 TW TW092102563A patent/TWI248362B/zh not_active IP Right Cessation
-
2000
- 2000-12-15 IS IS5771A patent/IS2253B/is unknown
-
2001
- 2001-01-29 NO NO20010489A patent/NO20010489L/no not_active Application Discontinuation
- 2001-01-30 HR HR20010079A patent/HRP20010079A2/hr not_active Application Discontinuation
- 2001-02-20 BG BG105277A patent/BG65309B1/bg unknown
- 2001-12-27 HK HK01109100A patent/HK1038198A1/xx not_active IP Right Cessation
-
2003
- 2003-08-15 NZ NZ527625A patent/NZ527625A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69929020D1 (de) | Rohrschuh | |
| DK0927168T3 (da) | 1,3-diheterocykliske metalloproteaseinhibitorer | |
| IS2494B (is) | Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni | |
| ID20637A (id) | Metode untuk menghambat pembentukan sulfida biogenik | |
| NO981305D0 (no) | Utblåsningssikring | |
| NO20001979L (no) | Anvendelse av inhibitorer av renin-angiotensin-systemet | |
| DE29713238U1 (de) | Wasserleitungsarmatur | |
| IS2253B (is) | Notkun á eletriptani til fyrirbyggingar á endurteknu mígreni | |
| ID21424A (id) | Konfigurasi katup gabungan untuk unit siklus-uap | |
| IT1303677B1 (it) | Dispositivo per il trattamento termico di pezzi. | |
| ATE252547T1 (de) | Matrixmetalloproteinaseinhibitoren | |
| DE69908330D1 (de) | 5-heteroaryl-substituierte indole | |
| NO307859B1 (no) | FremgangsmÕte for beregning av varighet av oppkoblinger | |
| DE29805665U1 (de) | Rohrverschraubung | |
| DE59912020D1 (de) | Duschgel | |
| DE29707764U1 (de) | Wasserhahn | |
| DE69905397D1 (de) | Selektive inhibitoren des mmp-12 | |
| DE29806956U1 (de) | Rohrverschraubung | |
| DE59707752D1 (de) | Steckbecken | |
| SI1100499T1 (en) | Use of eletriptan for the prevention of migraine recurrence | |
| NO20011268D0 (no) | Forbindelse til behandling av depresjon | |
| DE29822720U1 (de) | Duscheinheit | |
| DE29703225U1 (de) | Sparwasserhahn | |
| KR970024428U (ko) | 수도꼭지 | |
| IT1291076B1 (it) | Procedimento di inertizzazione di rifiuti contenenti amianto. |